How We're Getting The Vaccine To Our Patients: Heal's Dua
Dr. Renee Dua, Chief Medical Officer of Heal, discusses the best practices for vaccine distribution. Danielle DiMartino Booth, CEO and Chief Strategist for Quill Intelligence LLC, former adviser to th...
16 Des 202028min
Post-Vaccine World Will Embrace Globalization: Joel Hyatt
Joel Hyatt, Trustee Emeritus at the Brookings Institution and co-founder, Chairman and Chief Executive Officer of Globality, Inc., discusses his economic predictions for a post-vaccine world. Dr. Ames...
15 Des 202026min
Bonus: Game Changers, Part 4
As the earth is facing an increasingly consequential climate crisis, thinkers around the world are racing to find solutions. Many of them have been able to translate their eureka moments into action a...
15 Des 202011min
Value Investors Must Adapt or Face Failure: Bruce Greenwald
Bruce Greenwald, Professor Emeritus at Columbia Business School and Senior Advisor at First Eagle Investment Management, discusses his new book: "Value Investing: From Graham to Buffett and Beyond." C...
14 Des 202031min
3 Million Vaccine Doses Ready To Go Out Next Week: JHU's Sauer
Lauren Sauer, Johns Hopkins University Associate Professor of Emergency Medicine, on the latest news surrounding the coronavirus treatments, vaccines and spread. Barry Ritholtz, Founder of Ritholtz We...
11 Des 202026min
Mark Zuckerberg Always Knew What He Was Doing: Joe Nocera
Joe Nocera, Bloomberg Opinion columnist, discusses his column: "Facebook Has Only Itself to Blame for Drastic Remedy." Mandeep Singh, Senior Technology Analyst for Bloomberg Intelligence, discusses Ai...
10 Des 202027min
DoorDash Frenzy Shows Big Need For Retail Access to Pre-IPO Shares
Brianne Lynch, Head of Business Development & Partnerships at EquityZen, on the Airbnb and Doordash IPOs, and trading pre-IPO shares before they go public. Jim Vogel, Interest Rate Strategist for FHN ...
9 Des 202026min
'Astonishing' Astra Vaccine Reduces Asymptomatic Cases
Michelle Cortez, Health, Science and Medical Technology Reporter for Bloomberg, on AstraZeneca and Oxford's 'remarkable' covid-19 vaccine results. Dan Ives, Managing Director, Equity Research at Wedbu...
8 Des 202033min
